Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Cincinnati › NPI 1336478163
Hospital

Jewish Hospital LLC

Jewish Hospital LLC was paid $15.45M by Medicaid between Jan 2018 and Dec 2024, across 232 billing codes. Its largest line is 99283, emergency room visit (moderate) — 28% of everything it billed.

33Billing provider infoJEWISH HOSPITAL LLC
CINCINNATI, OH 45236
33aNPI1336478163assigned 12/07/2009
33bProvider typeGeneral Acute Care Hospital
28Total paid$15.45M
24GClaims418,640
24DCodes billed232
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#62 of 101
Median peer was paid$22.32M
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201828,327$1.24M
201920,204$997K
202015,563$1000K
202121,608$1.28M
202228,145$1.35M
2023177,235$5.85M
2024incomplete127,558$3.73M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 28% 35,849 32,970 $4.25M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 18% 22,541 19,626 $2.76M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.9% 9,785 8,004 $1.22M
96361 Intravenous infusion, hydration; each additional hour 4.6% 2,827 2,151 $707K
74177 Computed tomography, abdomen and pelvis; with contrast material 4.3% 2,715 2,224 $659K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.0% 9,322 7,115 $615K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.5% 9,732 2,927 $548K
70450 Computed tomography, head or brain; without contrast material 3.3% 2,397 1,981 $512K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.9% 4,100 3,865 $446K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.6% 1,252 1,066 $401K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.7% 1,128 666 $263K
G0378 Hospital observation service, per hour 1.6% 3,389 1,272 $252K
220 more codes
74176 Computed tomography, abdomen and pelvis; without contrast material 1.2% 783 $191K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.2% 1,734 $182K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.2% 4,688 $181K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.1% 1,755 $176K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 659 $125K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 978 $99K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 524 $97K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 886 $94K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 515 $92K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 161 $83K
76642 <1% 595 $70K
80048 Basic metabolic panel (calcium, ionized) <1% 16,664 $70K
70496 <1% 337 $65K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 222 $65K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 453 $62K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 323 $56K
71046 Radiologic examination, chest; 2 views <1% 6,956 $56K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,262 $56K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 157 $43K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 2,928 $43K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 3,240 $40K
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 427 $39K
99213 Doctor's office visit, returning patient (routine) <1% 402 $37K
97161 <1% 1,334 $35K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 1,273 $32K
71250 <1% 373 $29K
93017 <1% 346 $28K
80053 Comprehensive metabolic panel <1% 9,815 $25K
12001 <1% 159 $24K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 335 $22K
71275 Computed tomographic angiography, chest, with contrast material <1% 117 $22K
72125 Computed tomography, cervical spine; without contrast material <1% 771 $20K
72100 <1% 587 $19K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 119 $18K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 11,709 $18K
76536 <1% 127 $16K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 202 $16K
93971 <1% 226 $15K
97116 <1% 617 $14K
73562 <1% 762 $14K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 29,924 $14K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,040 $13K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 5,803 $12K
84484 <1% 8,501 $12K
73630 <1% 1,145 $12K
70486 <1% 162 $11K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 864 $11K
86900 <1% 811 $11K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 10,309 $10K
97016 <1% 319 $9K
70551 Magnetic resonance imaging, brain; without contrast material <1% 65 $9K
73130 <1% 864 $9K
88341 <1% 148 $9K
73030 <1% 752 $9K
71045 Radiologic examination, chest; single view <1% 3,525 $8K
97166 <1% 254 $8K
76830 Ultrasound, transvaginal <1% 254 $8K
70491 <1% 31 $8K
77066 Tomosynthesis, mammo <1% 244 $8K
C9290 Injection, bupivacaine liposome, 1 mg <1% 81 $8K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,656 $7K
80047 <1% 480 $7K
96375 Therapeutic injection; each additional sequential IV push <1% 5,560 $7K
99152 <1% 611 $7K
72131 <1% 84 $7K
97535 Self-care/home management training, each 15 minutes <1% 474 $7K
94060 <1% 56 $7K
77065 Tomosynthesis, mammo <1% 224 $7K
90715 <1% 479 $7K
94664 <1% 408 $7K
73502 <1% 498 $7K
71271 <1% 42 $6K
97162 <1% 442 $6K
73610 <1% 840 $6K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,225 $6K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,647 $6K
86850 <1% 795 $5K
10060 <1% 34 $5K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 497 $4K
84703 <1% 10,750 $4K
88307 <1% 75 $4K
94726 <1% 65 $4K
96376 <1% 1,818 $4K
36415 Collection of venous blood by venipuncture <1% 11,052 $4K
80076 <1% 2,946 $4K
94729 <1% 75 $4K
73110 <1% 472 $4K
83605 <1% 2,353 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 1,028 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 5,984 $3K
81001 <1% 10,776 $3K
83735 <1% 3,664 $3K
75574 <1% 15 $3K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 25 $3K
72040 <1% 87 $3K
J3490 Unclassified drugs <1% 140 $3K
97014 <1% 100 $3K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,083 $3K
74018 <1% 116 $2K
70498 <1% 294 $2K
80069 <1% 609 $2K
73560 <1% 261 $2K
83690 <1% 5,817 $2K
83880 <1% 2,186 $2K
82565 <1% 268 $2K
73590 <1% 189 $2K
87210 <1% 1,810 $2K
85027 <1% 1,308 $2K
90674 <1% 63 $1K
93975 <1% 15 $1K
85610 <1% 2,252 $1K
82077 <1% 933 $1K
C1769 Guide wire <1% 541 $1K
99153 Mod sedat endo service >5yrs <1% 118 $1K
81003 <1% 3,145 $1K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,373 $1K
90686 <1% 88 $1K
82803 <1% 1,977 $1K
84443 Thyroid stimulating hormone (TSH) <1% 376 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 513 $881.60
80061 Lipid panel <1% 116 $803.78
J1170 Injection, hydromorphone, up to 4 mg <1% 3,009 $787.39
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,634 $734.42
97165 <1% 14 $650.97
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 15 $644.77
86140 <1% 422 $628.97
85379 <1% 1,086 $619.97
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 522 $576.51
87077 <1% 949 $568.84
87081 <1% 1,205 $568.13
80143 <1% 338 $557.55
84702 <1% 491 $499.28
88342 <1% 463 $461.33
87186 <1% 818 $460.74
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,531 $452.70
73140 <1% 144 $451.56
85730 <1% 517 $422.03
86901 <1% 811 $386.77
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,329 $374.09
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,767 $373.46
J2800 Injection, methocarbamol, up to 10 ml <1% 377 $370.02
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,913 $358.60
J2704 Injection, propofol, 10 mg <1% 7,095 $350.41
00731 <1% 866 $344.85
80179 <1% 322 $305.96
87040 <1% 717 $304.62
72070 <1% 13 $254.12
00813 <1% 186 $223.55
J7030 Infusion, normal saline solution , 1000 cc <1% 844 $221.14
84132 <1% 366 $211.05
96367 <1% 117 $204.68
71101 <1% 26 $172.72
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,624 $172.14
88304 <1% 230 $159.92
J7120 Ringers lactate infusion, up to 1000 cc <1% 805 $155.69
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 680 $153.10
J0780 Injection, prochlorperazine, up to 10 mg <1% 773 $145.20
85652 <1% 363 $144.95
J2785 Injection, regadenoson, 0.1 mg <1% 36 $142.66
G0008 Administration of influenza virus vaccine <1% 171 $139.29
J1644 Injection, heparin sodium, per 1000 units <1% 1,128 $131.78
73080 <1% 71 $130.48
J1790 Injection, droperidol, up to 5 mg <1% 878 $130.27
J0690 Injection, cefazolin sodium, 500 mg <1% 1,292 $128.23
73090 <1% 61 $121.95
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,498 $112.26
00811 <1% 65 $108.70
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,008 $108.65
J3370 Injection, vancomycin hcl, 500 mg <1% 568 $101.90
00812 <1% 62 $85.95
87088 <1% 90 $78.06
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,115 $76.66
84100 <1% 103 $72.99
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 344 $69.87
87205 <1% 300 $69.59
87070 <1% 218 $67.85
J3475 Injection, magnesium sulfate, per 500 mg <1% 674 $67.65
84145 <1% 38 $67.40
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 233 $63.60
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg <1% 568 $63.55
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,120 $61.37
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 632 $60.22
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 445 $58.28
J8501 Aprepitant, oral, 5 mg <1% 27 $57.12
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 269 $41.50
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,832 $36.72
J0360 Injection, hydralazine hcl, up to 20 mg <1% 144 $35.72
J2550 Injection, promethazine hcl, up to 50 mg <1% 94 $31.04
94761 <1% 875 $30.60
J2060 Injection, lorazepam, 2 mg <1% 358 $29.87
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 930 $23.29
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 105 $20.38
82550 <1% 112 $18.05
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 1,919 $16.63
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 60 $14.69
J2470 Injection, pantoprazole sodium, 40 mg <1% 44 $9.89
J1596 Injection, glycopyrrolate, 0.1 mg <1% 459 $9.53
J1580 Injection, garamycin, gentamicin, up to 80 mg <1% 21 $8.76
J7050 Infusion, normal saline solution, 250 cc <1% 88 $8.70
J1171 Injection, hydromorphone, 0.1 mg <1% 257 $2.87
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 140 $1.67
J3480 Injection, potassium chloride, per 2 meq <1% 109 $1.14
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 48 $0.36
J8540 Dexamethasone, oral, 0.25 mg 0% 31 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 44 $0.00
C9399 Unclassified drugs or biologicals 0% 105 $0.00
94760 0% 106 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 0% 193 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 16 $0.00
87807 0% 15 $0.00
A4217 Sterile water/saline, 500 ml 0% 12 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 51 $0.00
A9576 Injection, gadoteridol, (prohance multipack), per ml 0% 308 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 61 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 32 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 39 $0.00
76376 0% 13 $0.00
A4641 Radiopharmaceutical, diagnostic, not otherwise classified 0% 14 $0.00
00400 0% 14 $0.00
C1776 Joint device (implantable) 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDAVIS-HAGENS, PATRICIA (PRESIDENT / CEO)